GO
Loading...

Drugs

More

  • Pot plants slurp up California's water supply Monday, 7 Jul 2014 | 1:28 PM ET

    Scientists say if no action is taken during California's extreme drought, there could be dire and irreversible consequences for wildlife.

  • July 7- Endo International Plc and BioDelivery Sciences International Inc said their experimental pain drug was found effective in a second late-stage trial, taking the drug a step closer to a marketing approval.

  • Maybe those foreign Rx drugs aren't so shady Sunday, 6 Jul 2014 | 11:30 AM ET

    While there are weaknesses in the alternative market of prescription drugs, the risks are not always as serious as some claim.

  • Ordering discount prescriptions? Buyer beware Saturday, 5 Jul 2014 | 12:02 PM ET

    Internet drugstores and their facilitators may claim to be safe, low-cost alternatives to pharmacies. But consumers need to be cautious.

  • Why it may be harder to get customized drugs Thursday, 3 Jul 2014 | 12:31 PM ET
    Express Scripts Inc.'s headquarters stands in St. Louis, Missouri.

    The largest U.S. pharmacy benefit manager, Express Scripts, is cutting back on compounded medications, saying most are ineffective or overpriced.

  • Paulson & Co said to amass large stake in Allergan Wednesday, 25 Jun 2014 | 4:53 PM ET
    A doctor draws Allergan Inc. Botox into a syringe before administering it to a patient at the offices of Marcus Facial Plastic Surgery in Redondo Beach, California

    Hedge fund Paulson & Co has amassed a large stake in Allergan and is supportive of a deal between the Botox maker and Valeant Pharmaceuticals.

  • Unholy smoke: Pope condemns legalization of pot Friday, 20 Jun 2014 | 8:49 AM ET
    Pope Francis.

    Legalizing recreational drugs won't produce the desired effects, Pope Francis told a drug enforcement conference. NBC News reports.

  • NY lawmakers reach agreement on medical marijuana Thursday, 19 Jun 2014 | 6:07 PM ET

    New York leaders have reached an agreement to legalize medical marijuana in New York.

  • Will ghoulish investments pay off? Monday, 16 Jun 2014 | 6:57 PM ET
    Elderly women wait for lunch to be served at a day care facility on Gogo Island in Matsuyama, Ehime Prefecture, Japan

    As the global population ages, some see investment opportunities in somewhat ghoulish bets the rates of cancer and other illnesses will rise.

  • Mexico's most feared drug cartel     Thursday, 12 Jun 2014 | 1:32 PM ET

    CNBC's Andrea Day looks into the FBI's investigation of the Los Zetas drug cartel, which used horse racing to launder money.

  • Orexigen shares plunge on FDA diet-drug delay Wednesday, 11 Jun 2014 | 7:33 AM ET

    Orexigen Therapeutics said the FDA delayed a decision on its obesity drug by three months, sending the company's shares down about 19 percent.

  • Merck proud to be a US-based company: CEO Wednesday, 4 Jun 2014 | 8:52 AM ET
    Ken Frazier, president and CEO of Merck.

    But Merck chief Kenneth Frazier also said the government needs to modify its high corporate tax code to level the playing field for American companies.

  • June 3- The city of Chicago has filed a lawsuit against five large narcotics makers alleging they contributed to the country's prescription drug epidemic by deceptively promoting their painkillers.

  • Chicago sues drugmakers, alleging painkiller risk Tuesday, 3 Jun 2014 | 10:37 AM ET

    Chicago filed a lawsuit against five pharmaceutical companies, accusing them of concealing the risks associated with certain painkillers.

  • Hate shots? New allergy options are on the way Monday, 2 Jun 2014 | 7:03 AM ET

    Patients can try new once-a-day tablets that dissolve quickly under the tongue and raise tolerance to grass or ragweed pollen, much like the shots.

  • What new GSK cancer deal shows about pharma market Monday, 2 Jun 2014 | 3:33 AM ET

    The announcement that GSK is planning to spend $350 million plus to get a slice of a U.K. biotech's cancer drugs has raised eyebrows.

  • Immunotherapies hit ASCO     Thursday, 29 May 2014 | 3:35 PM ET

    This year's biggest cancer conference begins tomorrow. CNBC's Meg Tirrell reports why immunotherapy drugs will be a key theme with drug makers at ASCO.

  • GSK invites private equity bid for drugs: Sources Thursday, 29 May 2014 | 12:34 PM ET
    A GlaxoSmithKline Plc logo sits on a sign outside the company's headquarters in London, U.K.

    GSK has invited private equity firms to consider making offers for a range of its older drugs, three people with direct knowledge of the matter said.

  • NEW YORK, May 29- Three Connecticut doctors billed Medicare for nearly 24,000 drug tests in 2012- on just 145 patients. Despite the extraordinary number, Medicare administrators paid the doctors a total of $1.4 million, according to a Reuters analysis of government payments to health providers.

  • Ataluren drives PTC Therapeutics     Friday, 23 May 2014 | 10:25 AM ET

    CNBC's Meg Tirrell reports shares of PTC Therapeutics are surging on a recommendation of the drug "Ataluren" designed to treat Duchenne muscular dystrophy which could be a billion dollar drug.